United States· US:87188-104_5b09994d-c28b-5ddc-e063-6294a90ac768

Argatroban

A argatroban product containing argatroban, registered in United States by Plano Pharmaceuticals Inc.. The same ATC class is registered in 11 of our 19 countries.

ATC B01AE03

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedArgatrobanATCB01AE03REGISTER NO.US:87188-104_5b09994d…PACKS LISTED1CHECKEDSeptember 20, 2026

Where it is registered

Argatroban is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AE03 (argatroban), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose

Argatroban · ATC B01AE03

11 / 19 countries

  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ARGATROBAN
Manufacturer
Plano Pharmaceuticals Inc.
Country
United States (US)
ATC code
B01AE03
ATC class
Argatroban
Defined daily dose
0.2 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 20, 2026

Packs & prices · 1

  • ndc11
    87188-104-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for argatroban.

Graded by severity as the source publishes them — 72 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Argatroban · interactions on record

158 records

  • 72 severe
  • 81 moderate
  • 5 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Argatroban in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All argatroban products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Austria · Argatra, Argatra Multidose
  • Germany · Argatra, Argatra Multidose
  • Denmark · Novastan
  • Spain · Arganova
  • Finland · Novastan
  • France · Arganova, Argatroban Accord
  • United Kingdom (Northern Ireland) · Argatroban Accord Healthcare, Exembol
  • Italy · Novastan
  • Netherlands · Arganova Multidose
  • Norway · Novastan
  • Sweden · Novastan, Novastan Multidos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/594f1547-0136-4df1-a15a-f6cbca83496c
GET /v1/drugs/594f1547-0136-4df1-a15a-f6cbca83496c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "125",
  "substance": "ARGATROBAN",
  "productndc": "87188-104",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/125mL",
  "application_number": "NDA022485",
  "marketing_category": "NDA"
}

See everything about argatroban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.